Jazz Pharmaceuticals (JAZZ) Misses Q1 EPS by 22c; Lowers Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq rallies as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 232.01 +17.57 (8.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.44 | 52 Week High | $160.00 | |||
| Open | $225.37 | 52 Week Low | $95.80 | |||
| Day High | $233.74 | P/E | 43.12 | |||
| Day Low | $218.53 | EPS | $5.38 | |||
| Volume | 1,023,437 | |||||
